11 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
the synergistic potential of combining these two technologies in the pursuit of our mission.
We have assembled a team with extensive experience in complex … of the underwriters option to purchase additional shares in the IPO.
Our Strategy
Our mission is to develop new medicines to treat and cure patients with solid
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
5 Mar 24
Regulation FD Disclosure
8:30am
. Disclaimers
Turnstone is Pioneering Advancements in Selected TIL Therapy Next-Generation Therapy Designed to Treat and Cure Solid Tumors OUR MISSION
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
, among other facilities in circumstances where the FDA determines that such remote evaluation would be appropriate based on mission needs and travel
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
our current pipeline, though we continue to explore the synergistic potential of combining these two technologies in the pursuit of our mission.
We … and Related Party Transactions” for more information.
Our Strategy
Our mission is to develop new medicines to treat and cure patients with solid tumors using
S-1/A
flyeuo
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
o1rqb0c1 tui5
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
p0cxswifr01fnvd
22 Jun 23
Letter from SEC
12:00am
S-1
f9jbdvip
12 Jun 23
IPO registration
4:28pm
DRS
9grzjisj nf
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next